Five9 appoints Maria Walker to Board of Directors effective May 21, 2024

Five9, Inc.

Walker appointed as Class I Director; term expires at 2027 annual meeting.
She will serve on the Audit Committee.
Initial RSU grants: $400,000 vesting over 3 years and $200,000 vesting in 1 year.
Walker is former CFO of Patient Square Capital (retired Dec 2023) and ex-KPMG audit partner.
No related-party transactions or arrangements in connection with appointment.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Maria Walker

Class I Director

FIVN · Five9, Inc.

Effective: 2024-05-21
Filed: May 22, 2024, 7:59 PM ET

On May 21, 2024, the Board of Directors (the “Board”) of Five9, Inc. (the “Company”) appointed Ms. Maria Walker to serve on the Board.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Maria Walker was appointed as Class I Director at Five9, Inc..

Action: appointed
Role: Class I Director

Exact text from the filing

On May 21, 2024, the Board of Directors (the “Board”) of Five9, Inc. (the “Company”) appointed Ms. Maria Walker to serve on the Board.

View on SEC.gov

Five9, Inc. filing history →

Source: SEC EDGAR

accession 0001288847-24-000085

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.